高錳酸鉀：市場佔有率分析、產業趨勢與統計、成長預測（2024-2029）

預計2024年高錳酸鉀市場規模為9.3億美元，預計到2029年將達到11.3億美元，在預測期內（2024-2029年）增加41.1億美元，複合年成長率為%。

冠狀病毒感染疾病（COVID-19）的爆發對農業、水處理和其他最終用戶行業等各個行業產生了短期和長期影響，從而影響了高錳酸鉀市場。農業產業受到供應鏈中斷和化學品製造公司停產的廣泛影響。這是由於封鎖和勞動力短缺，對高錳酸鉀市場產生了不利影響。例如，在世界各地，歐洲的封鎖嚴重擾亂了食品供應鏈。據先正達稱，歐洲約 46% 的大型農業企業受到了 COVID-19 大流行的影響。因此，COVID-19封鎖對上述產業的營運和成長的負面影響減少了這些產業對高錳酸鉀的需求。

主要亮點

• 從長遠來看，對高品質水處理的需求不斷成長以及作為化學品中間體的使用不斷增加正在推動市場成長。
• 與使用高錳酸鉀相關的健康風險預計將阻礙市場成長。

高錳酸鉀市場走勢

製藥業需求不斷成長

• 高錳酸鉀擴大用於醫學，特別是用於防腐目的。高錳酸鉀可治療各種皮膚病，如皮膚炎、濕疹、痤瘡和其他真菌感染疾病。
• 醫生建議有丘疹和水泡的人使用高錳酸鉀。高錳酸鉀的氧化作用會破壞正在生長的真菌。因此，運動員通常會將其塗在腳上以減輕疼痛。
• 據Astra Zeneca稱，2024年北美將佔據藥品銷售的主要佔有率，預計為6,330億美元。歐盟（不包括英國）以 2,870 億美元位居第二，其次是東南亞和東亞，預計將達到創紀錄的 2,320 億美元。
• 德國是世界上最大的製藥工業中心之一，約有 400 家公司駐紮於此。此外，根據歐洲製藥工業協會聯合會的數據，2022年德國在製藥業的研發支出方面將超過瑞士、英國和法國，以84.66億歐元（約89.21億美元）位居第一。花時間研究。
• 德國醫藥市場被世界領先的醫藥製造公司視為最有前途的子部門，這些公司正在向德國擴張，以鞏固其在全球市場的地位。例如，2022年8月，全球領先的製藥公司拜耳投資2.75億歐元（約2.87億美元）在勒沃庫森基地開發Solida-1藥品生產設施。該設施計劃於 2024 年投入運作。
• 全球製藥公司輝瑞透露，2022年其總收益將有史以來首次突破1,000億美元，創下全球製藥製造商的紀錄。該公司預計2022年總收益約為1,003.3億美元。
• 因此，不斷擴大的藥品產能和對藥品的高需求預計將在預測期內推動高錳酸鉀的發展。

亞太地區主導市場

• 由於亞太地區高度發展的醫療保健產業以及多年來對水處理和農業領域的持續投資，亞太地區可能會主導全球市場。
• 近年來，該地區紡織業使用的高錳酸鉀有所增加。高錳酸鉀噴霧劑主要用於丹寧布料布漂白、漂白，使其光澤。
• 高錳酸鉀用於水處理應用，以去除毒素和玫瑰藻。在亞太地區，預計清潔水需求的增加和水處理設施的擴建將支持高錳酸鉀的未來使用。
• 印度藥品出口促進委員會（Pharmexcil）秘書長表示，2021-22年印度出口了價值約246.2億美元的醫藥產品，包括原料藥成分/藥物中間體。此外，2022年4月至10月，印度藥品出口成長4.22%，達145.7億美元。上一會計年度同期出口額為139.8億美元。
• 根據全印度原產地化學家和經銷商透露的資料，印度製藥業的銷售額到 2022 年 11 月將與前一年同期比較健康成長 17.3%，到 2022 年 12 月將與前一年同期比較10.4%。我做到了這一點。 2022年12月，產量成長1.5%。與前一年同期比較成長%，其中藥品價格上漲6.8%。預計2022-23會計年度剩餘三個月醫藥產業成長率將持續上升9-10%。這與2022-23年前9個月9.1%的平均與前一年同期比較成長率相符。
• 此外，根據中國國家統計局的數據，2023年農作物生產總產值預計將達到1.23兆美元。 2021年中國農業生產收益為1.13兆美元，2022年為1.18兆美元。到 2025 年，收益預計將達到 1.3 兆美元。
• 預計上述因素將在預測期內推動該地區的市場。

高錳酸鉀產業概況

高錳酸鉀市場部分分散，參與者眾多。主要企業包括重慶長園Group Limited、Carus Group Inc.、Organic Industries Pvt Ltd.、GFS Chemicals, Inc.、廣東航新科技有限公司等。

其他福利

• Excel 格式的市場預測 (ME) 表
• 3 個月分析師支持

目錄

第1章簡介

• 調查先決條件
• 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

• 促進因素
  • 對高品質水處理的需求不斷成長
  • 製藥業的使用增加
  • 其他司機
• 抑制因素
  • 相關健康問題
  • 其他阻礙因素
• 價值鏈分析
• 產業吸引力－波特五力分析
  • 供應商的議價能力
  • 買方議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭程度

第5章市場區隔（以金額為準的市場規模）

• 按最終用戶產業
  • 藥品
  • 水處理
  • 食品和飲料
  • 農業
  • 其他
• 按地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 其他歐洲國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲

第6章 競爭形勢

• 併購、合資、聯盟、協議
• 市場佔有率(%)/排名分析
• 主要企業策略
• 公司簡介
  • Carus Group Inc.
  • Changsha Yonta
  • Chongqing Changyuan Group Limited.
  • GFS Chemicals, Inc.
  • Guangdong Hangxin Technology Co., Ltd
  • Libox Chem（India）Pvt. Ltd.
  • Magnesia
  • Milport Enterprises, Inc.
  • Nippon Chemical Industrial CO., LTD.
  • Otto Chemie Pvt. Ltd.
  • Univar Solutions Inc.
  • Universal Chemicals & Industries Pvt. Ltd.

第7章 市場機會及未來趨勢

The Potassium Permanganate Market size is estimated at USD 0.93 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 4.11% during the forecast period (2024-2029).

The COVID-19 outbreak brought several short-term and long-term consequences in various industries, such as agriculture, water treatment, and other end-user industries, affecting the potassium permanganate market. The agriculture industry was widely impacted due to supply chain disruption and a halt in the production of chemical manufacturing companies. It is due to lockdown and workforce shortages, thus, adversely affecting the potassium permanganate market. For instance, worldwide, the lockdowns in Europe greatly disrupted food supply chains. According to Syngenta, about 46% of large European farming businesses were impacted by the COVID-19 pandemic. Hence, the negative impact of the COVID-19 lockdown on the operations and growth of the industries mentioned above declined the demand for potassium permanganate in these industries.

Key Highlights

• Over the long term, the growing need for high-quality water treatment and the increasing usage as an intermediate in chemicals are driving the market growth.
• The associated health risks of using potassium permanganate are expected to hinder market growth.

Potassium Permanganate Market Trends

Growing Demand from Pharmaceutical Industry

• Potassium permanganate is increasingly used in medicine, particularly for antiseptic purposes. Potassium permanganate treats various skin illnesses, including dermatitis, eczema, acne, and other fungal infections.
• Doctors recommend potassium permanganate for those who include gushing wounds and blisters. The oxidizing action of potassium permanganate destroys the growing fungus. Hence athletes typically use it on their feet for pain alleviation.
• According to AstraZeneca, the projected pharmaceutical sales in 2024 are expected to be USD 633 billion for North America, holding the major share. It is followed by the European Union (excluding the United Kingdom) with USD 287 billion at the second position, and then Southeast and East Asia is expected to register USD 232 billion.
• Germany is one of the world's largest locations in the pharmaceutical industry, with nearly 400 companies. Furthermore, as of 2022, according to the European Federation of Pharmaceutical Industries and Associations, Germany led the way in terms of pharma industry R&D spending, ahead of Switzerland, the United Kingdom, and France, with EUR 8,466 million (~USD 8,921 million) spend on research.
• The pharmaceutical market in Germany is identified as a top-prospect sub-sector by world-leading pharmaceutical manufacturing companies, which are expanding into the country to strengthen their position in the global market. For instance, in August 2022, the key global pharmaceutical player, Bayer, underwent the development of the Solida-1 pharmaceutical production facility at its site in Leverkusen for an investment of EUR 275 million (~USD 287 million). The facility is expected to come on stream in 2024.
• Pfizer, a global pharmaceutical company, revealed that its total revenue exceeded USD 100 billion in 2022 for the first time in its history, a record among global drug manufacturers. The company estimated a total revenue of approximately USD 100,330 million in 2022.
• Therefore, the continuously expanding pharmaceutical production capabilities and the high demand for pharmaceuticals are expected to drive the potassium permanganate forward during the forecast period.

Asia-Pacific to Dominate the Market

• Asia-Pacific will likely dominate the global market due to the region's highly developed healthcare sector and ongoing investments in the water treatment and agriculture sectors over the years.
• Potassium permanganate used in the region's textile sector increased in recent years. Potassium permanganate spray is mostly used to brighten denim textiles by decolorizing and bleaching them.
• Potassium permanganate is used in water treatment applications to remove toxins and algae rose. The Asia-Pacific region's growing need for clean water and expanding water treatment facilities are projected to support potassium permanganate used in the future.
• According to the Director General of the Pharmaceutical Export Promotion Council of India (Pharmexcil), India exported INR 1,75,040 crore (~USD 24.62 billion) worth of pharmaceutical products, including bulk drugs/drug intermediates, in FY 2021-22. Furthermore, India's pharmaceutical exports increased by 4.22% from April to October 2022, reaching USD 14.57 billion. The exports were valued at USD 13.98 billion during the same period in the previous fiscal.
• As per the data revealed by the All-Indian Origin Chemists and Distributors, the sales of the Indian pharmaceutical industry delivered a healthy growth of 17.3% y-o-y in November 2022 and 10.4% y-o-y in December 2022. In December 2022, the production volume registered 1.5% y-o-y growth while prices of the pharma products climbed 6.8%. The growth figures in the pharmaceutical industry during the remaining 3 months of FY 2022-23 are expected to stay up by 9-10%. They are in line with the average growth rate of 9.1% y-o-y in the first nine months of FY 2022-23.
• Moreover, according to the National Bureau of Statistics of China, the gross production value in crop production is projected to amount to USD 1.23 trillion in 2023. The revenue from crop production in China accounted for USD 1.13 trillion in 2021 and USD 1.18 trillion in 2022. It is estimated that the revenue will reach USD 1.30 trillion in 2025.
• The factors above are expected to drive the market in the region during the forecast period.

Potassium Permanganate Industry Overview

The potassium permanganate market is partially fragmented, with several players. Some major companies are Chongqing Changyuan Group Limited, Carus Group Inc., Organic Industries Pvt Ltd., GFS Chemicals, Inc., and Guangdong Hangxin Technology Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Drivers
  • 4.1.1 Growing Need for High-Quality Water Treatment
  • 4.1.2 Increasing Usage in the Pharmaceutical Industry
  • 4.1.3 Other Drivers
• 4.2 Restraints
  • 4.2.1 Associated Health Issues
  • 4.2.2 Others Restraints
• 4.3 Industry Value Chain Analysis
• 4.4 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.4.1 Bargaining Power of Suppliers
  • 4.4.2 Bargaining Power of Buyers
  • 4.4.3 Threat of New Entrants
  • 4.4.4 Threat of Substitute Products and Services
  • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Value)

• 5.1 By End-user Industry
  • 5.1.1 Pharmaceutical
  • 5.1.2 Water Treatment
  • 5.1.3 Food and Beverage
  • 5.1.4 Agriculture
  • 5.1.5 Other End-user Industries
• 5.2 By Geography
  • 5.2.1 Asia-Pacific
    • 5.2.1.1 China
    • 5.2.1.2 India
    • 5.2.1.3 Japan
    • 5.2.1.4 South Korea
    • 5.2.1.5 Rest of Asia-Pacific
  • 5.2.2 North America
    • 5.2.2.1 United States
    • 5.2.2.2 Canada
    • 5.2.2.3 Mexico
  • 5.2.3 Europe
    • 5.2.3.1 Germany
    • 5.2.3.2 United Kingdom
    • 5.2.3.3 France
    • 5.2.3.4 Italy
    • 5.2.3.5 Rest of Europe
  • 5.2.4 South America
    • 5.2.4.1 Brazil
    • 5.2.4.2 Argentina
    • 5.2.4.3 Rest of South America
  • 5.2.5 Middle-East and Africa
    • 5.2.5.1 Saudi Arabia
    • 5.2.5.2 South Africa
    • 5.2.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
• 6.2 Market Share (%)**/Ranking Analysis
• 6.3 Strategies Adopted by Leading Players
• 6.4 Company Profiles
  • 6.4.1 Carus Group Inc.
  • 6.4.2 Changsha Yonta
  • 6.4.3 Chongqing Changyuan Group Limited.
  • 6.4.4 GFS Chemicals, Inc.
  • 6.4.5 Guangdong Hangxin Technology Co., Ltd
  • 6.4.6 Libox Chem (India) Pvt. Ltd.
  • 6.4.7 Magnesia
  • 6.4.8 Milport Enterprises, Inc.
  • 6.4.9 Nippon Chemical Industrial CO., LTD.
  • 6.4.10 Otto Chemie Pvt. Ltd.
  • 6.4.11 Univar Solutions Inc.
  • 6.4.12 Universal Chemicals & Industries Pvt. Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

• 7.1 Government Initiatives Focusing on the Supply of Treated Soft Water
• 7.2 Other Opportunities